Saw palmetto for benign prostatic hyperplasia.

@article{Bent2006SawPF,
  title={Saw palmetto for benign prostatic hyperplasia.},
  author={Stephen Bent and Christopher J. Kane and Katsuto Shinohara and John M. Neuhaus and Esther Sid Hudes and Harley Goldberg and Andrew L. Avins},
  journal={The New England journal of medicine},
  year={2006},
  volume={354 6},
  pages={
          557-66
        }
}
BACKGROUND Saw palmetto is used by over 2 million men in the United States for the treatment of benign prostatic hyperplasia and is commonly recommended as an alternative to drugs approved by the Food and Drug Administration. METHODS In this double-blind trial, we randomly assigned 225 men over the age of 49 years who had moderate-to-severe symptoms of benign prostatic hyperplasia to one year of treatment with saw palmetto extract (160 mg twice a day) or placebo. The primary outcome measures… 
Saw palmetto for benign prostatic hyperplasia: just how effective is it?
TLDR
This randomized, double-blind study was conducted in men aged >49 years with moderate-to-severe BPH symptoms, and a history of prostate cancer, BPH surgery, urethral stricture, or neurogenic bladder.
Effects of Roystonea Regia (D-004) and Saw Palmetto Lipid Extracts in Men with Symptomatic benign Prostatic Hyperplasia
TLDR
D-004 (320 mg/day), a lipid extract of Roystonea regia fruits, reduced experimental prostate hyperplasia in rodents and the International Prostate Symptoms Score (IPSS) as effectively as SP in a pilot trial in men with BPH.
Serenoa repens for benign prostatic hyperplasia.
TLDR
The main outcome measure for comparing the effectiveness of Serenoa repens with placebo or other interventions was the change in urologic symptom-scale scores, and secondary outcomes included changes in nocturia and urodynamic measures.
Diagnóstico e tratamento da hiperplasia benigna da próstata Diagnosis and treatment of benign prostatic hyperplasia
TLDR
Benign prostatic hyperplasia is a highly prevalent disease whose treatment should be individualized and started before the onset of major complications, and the expectant treatment for mild cases should be considered.
What do we know about phytotherapy of benign prostatic hyperplasia?
Benign prostatic hyperplasia: An overview of existing treatment
TLDR
Clinical efficacy of either 5α-reductase inhibitor or α1-AR antagonist has been further improved by using combination therapy; however, long-term outcomes are still awaited.
...
...

References

SHOWING 1-10 OF 48 REFERENCES
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
TLDR
Among men with symptoms of urinary obstruction and prostatic enlargement, treatment with finasteride for four years reduces symptoms and prostate volume, increases the urinary flow rate, and reduces the probability of surgery and acute urinary retention.
Serenoa repens for benign prostatic hyperplasia.
TLDR
The evidence suggests that Serenoa repens improves urologic symptoms and flow measures compared with placebo and is associated with fewer adverse treatment events.
The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
TLDR
In men with benign prostatic hyperplasia, terazosin was effective therapy, whereas finasteride was not, and the combination of terazOSin and finasterside was no more effective than terazoshin alone.
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
TLDR
Long-term combination therapy with doxazosin and finasteride was safe and reduced the risk of overall clinical progression of benign prostatic hyperplasia significantly more than did treatment with either drug alone.
Placebo-Controlled Evaluation of the Efficacy and Tolerability of Permixon® in Benign Prostatic Hyperplasia after Exclusion of Placebo Responders
TLDR
Permixon® appears to be significantly more effective than placebo and well tolerated in the short term treatment of mild to moderate symptomatic BPH.
...
...